EcoR1 Capital, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
EcoR1 Capital, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$52,958,664
-20.6%
5,806,871
-7.9%
1.79%
+9.2%
Q2 2023$66,726,695
-17.8%
6,306,871
-5.0%
1.64%
-37.5%
Q1 2023$81,187,277
-1.5%
6,638,3710.0%2.61%
+4.3%
Q4 2022$82,382,184
-9.2%
6,638,3710.0%2.51%
-6.3%
Q3 2022$90,680,000
-25.5%
6,638,3710.0%2.68%
-36.3%
Q2 2022$121,681,000
+14.0%
6,638,3710.0%4.20%
+25.8%
Q1 2022$106,745,000
+104.7%
6,638,371
+78.2%
3.34%
+100.9%
Q4 2021$52,142,000
-25.3%
3,724,4370.0%1.66%
-31.5%
Q3 2021$69,759,000
-10.2%
3,724,4370.0%2.43%
-16.4%
Q2 2021$77,655,000
-25.6%
3,724,437
+0.9%
2.90%
-37.3%
Q1 2021$104,391,000
+80.3%
3,692,637
+108.3%
4.63%
+48.7%
Q4 2020$57,907,000
-59.0%
1,773,037
-61.5%
3.11%
-69.1%
Q3 2020$141,205,000
+88.0%
4,608,5290.0%10.07%
+81.5%
Q2 2020$75,119,000
+115.0%
4,608,529
+31.2%
5.55%
+52.0%
Q1 2020$34,941,000
-40.1%
3,511,690
-17.2%
3.65%
-30.6%
Q4 2019$58,327,000
-4.9%
4,241,953
+4.9%
5.26%
-32.1%
Q3 2019$61,316,000
-41.0%
4,041,953
-23.4%
7.74%
-26.3%
Q2 2019$103,899,000
+18.7%
5,276,7530.0%10.50%
+30.1%
Q1 2019$87,541,000
+18.2%
5,276,7530.0%8.07%
+8.9%
Q4 2018$74,086,000
+8.5%
5,276,753
+35.2%
7.41%
+20.5%
Q3 2018$68,302,000
-3.9%
3,902,975
-0.0%
6.15%
-9.1%
Q2 2018$71,065,000
+0.6%
3,904,675
+3.7%
6.77%
-4.5%
Q1 2018$70,628,000
+22.5%
3,766,8520.0%7.08%
+9.2%
Q4 2017$57,633,000
+2.3%
3,766,8520.0%6.49%
-13.5%
Q3 2017$56,314,000
+197.8%
3,766,852
+85.2%
7.50%
+123.5%
Q2 2017$18,913,000
-17.7%
2,033,622
-22.1%
3.36%
-42.2%
Q1 2017$22,985,000
+49.2%
2,611,9060.0%5.81%
+18.4%
Q4 2016$15,410,000
-5.6%
2,611,9060.0%4.91%
-2.1%
Q3 2016$16,324,000
+144.3%
2,611,906
+5.9%
5.01%
+90.2%
Q2 2016$6,681,000
-33.1%
2,465,2860.0%2.63%
-24.5%
Q1 2016$9,984,000
-51.5%
2,465,286
+0.6%
3.49%
-46.0%
Q4 2015$20,580,0002,450,0006.46%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders